Camelot Portfolios’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,000
| Closed | -$15.3K | – | 217 |
|
|
2025
Q1 | $15.3K | Buy |
+11,000
| New | +$15.3K | 0.01% | 204 |
|
|
2024
Q3 | – | Sell |
-11,000
| Closed | -$24.6K | – | 522 |
|
|
2024
Q2 | $24.6K | Buy |
+11,000
| New | +$24.6K | 0.01% | 352 |
|
|
2024
Q1 | – | Sell |
-11,000
| Closed | -$19.5K | – | 202 |
|
|
2023
Q4 | $19.5K | Buy |
+11,000
| New | +$19.5K | 0.01% | 208 |
|
|
2023
Q3 | – | Sell |
-11,000
| Closed | -$7.27K | – | 194 |
|
|
2023
Q2 | $7.27K | Hold |
11,000
| – | – | ﹤0.01% | 194 |
|
|
2023
Q1 | $8.77K | Buy |
+11,000
| New | +$8.77K | 0.01% | 179 |
|